Treatment with etanercept for patients with juvenile rheumatoid arthritis in Taiwan - A preliminary report

Journal of Microbiology, Immunology and Infection

Volumn 38, Issue 6, 2005, Pages 447-450

  Liang, Tien Chi ^a   Yang, Yao Hsu ^a   Lin, Yu Tsan ^a   Chiang, Bor Luen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Etanercept; Juvenile rheumatoid arthritis; Tumor necrosis factor alpha

Indexed keywords

ANTIRHEUMATIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CELECOXIB; COMPLEMENT COMPONENT C3 RECEPTOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; ETANERCEPT; MELOXICAM; METHOTREXATE; METHYLPREDNISOLONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ABSENCE OF SIDE EFFECTS; ANAMNESIS; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; MALE; SCHOOL CHILD; TAIWAN; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; TAIWAN;

EID: 33344468877     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Classidy JT. Rheumatic diseases of childhood. Juvenile rheumatoid arthritis. In: Kelly WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. Philedelphila: WB Saunders; 1997:1207-24.
2. Juvenile rheumatoid arthritis. In: Classidy JT, Petty RE, eds. Textbook of pediatric rheumatology. Philedelphila: WB Saunders; 1995:133-223.
3. Woo P, Wedderburn LR. Juvenile chronic arthritis. Lancet 1998;351:969-73.
4. Chu CQ, Field M, Feldmann M, Maini RN. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-32.
5. Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-5.
6. Mac Naul KL, Chartrain N, Lark M, Tocci MJ, Hutchinson NI. Differential effects of IL-1 and TNF alpha on the expression of stromelysin, collagenase and the natural inhibitor, TIMP, in rheumatoid synovial fibroblasts. Matrix Suppl 1992;1:198-9.
7. Garrison L, McDonnell ND. Etanercept: therapeutic use in patients with rheumatoid arthritis. Ann Rheum Dis 1999;58 (Suppl 1):165-9.
8. Spencer-Green G. Etanercept (Enbrel): update on therapeutic use. Ann Rheum Dis 2000;59(Suppl 1):i46-9.
9. Abrahmson S, Alarcon G, Arend W, et al. Primer on the rheumatic disease. In: Klippel JH, ed. Atlanta: Arthritis Foundation; 1997:455.
10. Brunner HI, Lovell DJ, Finck BK, Giannini EH. Preliminary definition of disease flare in juvenile rheumatoid arthritis. J Rheumatol 2002;29:1058-64.
11. Package insert, Enbrel (etanercept). Seattle, WA: Immunex Corporation, June 2000.
12. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993;151:1548-61.
13. Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patient with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999;340:253-9.
14. Johnson CJ, Reilly KM, Murray KM. Etanercept in juvenile rheumatoid arthritis. Ann Pharmacother 2001;35:464-71.
15. Vermeire S, Noman M, Van Assche G, Baert F, Van Steen K, Esters N, et al. Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study. Gastroenterology 2003;125:32-9.
16. Louis M, Rauch J, Armstrong M, Fitzcharles MA. Induction of autoantibodies during prolonged treatment with infliximab. J Rheumatol 2003;30:2557-62.